Abstract:It was found that calixarene C-107 (5,17-diamino(2-pyridyl)methylphosphono-11,23-di-tret-butyl-26,28-dihydroxy-25,27-dipropoxycalix[4]arene) could effectively reduce Na+,K(+)-ATPase activity of the myometrium cell plasmatic membranes (the value of the apparent constant of inhibition I0.5 was 33 +/- 4 nM) while it practically did not influence the "basal" Mg2(+)-ATPase activity of the same membrane. In comparative experiments, we have shown that the model calixarene C-150--the calixarene "scaffold" (26,28-dihydroxy-25,27-dipropoxycalix[4]arene), and the model compound M-3 (4-hydroxyaniline(2-pyridine)methylphosphonic acid)--a fragment of the calixarene C-107, had practically no influence on the enzymatic activities of Na+,K(+)-ATPase and Mg(2+)-ATPase over a wide range of concentrations. Hence, the influence of calixarene C-107 on Na+,K(+)-ATPase activity was caused by the joint action of two aminophosphonic substituents on the upper rim of the calixarene bowl. The isomer of calixarene C-107--calixarene C-160 (5,11-diamino(2-pyridyl)methylphosphono-17,23-di-tret-butyl-26,28-dihydroxy-25,27-dipropoxycalix[4]arene) also did not influence the Na+,K(+)-ATPase and Mg(2+)-ATPase activities of plasmatic membrane of myometrium cells. We carried out molecular modeling of calixarenes C-107 and C-160 and showed differences in interatomic distance between aminophosphonic substituents of mentioned calixarenes. We came to the conclusion that spatial structure of calixarene C-107, namely localization of two aminophosphonic substituents in 5,17 position of the upper rim of this calixarene, is crucial for inhibition of Na+,K(+)-ATPase activity. Using laser correlation spectroscopy it was found that the 100 microM solution of calixarene C-107 and 2.5% DMSO had microparticles with size range from 100 nm to 10 microm. Plasma membrane vesicles had average hydrodynamic diameter 401 +/- 17 nm, but after interaction of these vesicles with calixarene C-107 we have registered the creation of some particles with sizes greater than 10 microm. Therefore membrane vesicles agglutinated to each other and/ or to calixarene microparticles.

Structural Insight on the Selectivity of Calyx[4]Arene‐Based Inhibitors of Mg2+−Dependent Atp‐Hydrolases

[Spatial structure of the calixarene-aminophosphonic acids is important for their inhibition of the Na+,K(+)-ATPase activity in plasma membrane of smooth muscle cells]

The inhibitory influence of calix[4]Arene of C-90 on the activity of Ca2+,Mg2+-ATPases in plasma membrane and sarcoplasmic reticulum in myometrium cells

Structural Basis for Ion Selectivity Revealed by High-Resolution Crystal Structure of Mg 2+ Channel MgtE

E2P-like states of plasma membrane Ca2+‑ATPase characterization of vanadate and fluoride-stabilized phosphoenzyme analogues

Novel Cinobufagin Oxime Ether Derivatives As Potential Na+/ K+-Atpase Inhibitors: Synthesis, Biological Screening and Molecular Docking

Subtype-Specific Ligand Binding and Activation Gating in Homomeric and Heteromeric P2X Receptors

Exploring the mechanism of ion-pair recognition by new calix[4]pyrrole bis-phosphonate receptors: insights from quantum mechanics study

Functional Dissection of KATP Channel Structures Reveals the Importance of a Conserved Interface

The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

Caloxin-derived peptides for the inhibition of plasma membrane calcium ATPases

Atp-Dependent Modulation of Mgte in Mg2+ Homeostasis

A Critical Mobile Divalent Cation Site in the ATP-Binding Pocket of P2X3 Receptors That Controls Channel Gating

Structural identification of vasodilator binding sites on the SUR2 subunit

Recent Advances in the Structural Biology of Mg2+ Channels and Transporters

Magnesium Transporter MgtA revealed as a Dimeric P-type ATPase

Magnesium enhances aurintricarboxylic acid's inhibitory action on the plasma membrane Ca2+-ATPase

Functional approach to the catalytic site of the sarcoplasmic reticulum Ca(2+)-ATPase: binding and hydrolysis of ATP in the absence of Ca(2+)

Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore

Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs

Experimental and Theoretical Insights of Functionalized Hexavanadates on Na+/K+-ATPase Activity; Molecular Interaction Field, Ab Initio Calculations and in Vitro Assays.